Eculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double-Blind, Placebo-Controlled Trial

Project Details

Short titleEculizumab in Shiga-Toxin producing E. Coli Haemolytic Uraemic Syndrome (ECUSTEC): A Randomised, Double-Blind, Placebo-Controlled Trial
StatusFinished
Effective start/end date1/04/1631/03/22

Funding

  • NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE